MMP9 and neoplasm: Most studies predominantly focused on associations between beta-blockers and mediator enzymes (such as MMP-9) instead of examining their direct effect on clinical (e.g., survival and tumor progression) or physiological endpoints (e.g., cell proliferation and cell migration).